BRUSSELS, Nov 5 (Reuters) - Belgian biotech company OncoMethylome (ONCOB.BR: Quote, Profile, Research) unveiled plans to refocus its cancer diagnosis business and revealed it had lost a partner, pulling down its shares to a six-month low.The company, ...
[Reuters India - 11/05/2009]